Voltage-gated Ca 2+ (Ca V )c hannels mediate Ca 2+ entry into excitable cells to regulate am yriad of cellular events following membrane depolarization. We report the engineering of RGK GTPases,aclass of genetically encoded Ca V channel modulators,t oe nable photo-tunable modulation of Ca V channel activity in excitable mammalian cells.T his optogenetic tool (designated optoRGK) tailored for Ca V channels could find broad applications in interrogating aw ide range of Ca V -mediated physiological processes.
route of Ca 2+ entry into cells of the nervous and cardiovascular systems,a sw ell as other electrically excitable cells. [1] Ca V channels respond to membrane depolarization to permit Ca 2+ influx, thereby playing instrumental roles in Ca 2+dependent physiological processes,i ncluding neurotransmitter/hormone release,g ene expression, and muscle contraction. [1b, c] Deregulated Ca V channels can give rise to pathophysiological conditions ranging from cardiovascular disorders to psychiatric conditions. [2] Consequently,C a V channels are important targets for therapeutic intervention and physiological regulation. [3] Currently widely used Ca V channel blockers (e.g.,dihydropyridines) have prominent drawbacks, including off-target toxicity,l ack of spatial control, and nonreversibility. [3b,4] New interventional approaches to control Ca V channels are thus needed.
Optogenetics,w hich involves the incorporation of synthetic photosensitive modules into cells of living tissues to control cellular activities with high spatiotemporal precision, provides an ideal solution to overcome the drawbacks associated with conventional Ca V channel blockers. [5] The Ras-like GTPases Rad/Rem/Gem/Kir (RGK), which function as negative regulators of Ca V channels,are considered to be the prime candidates for generating optogenetic tools to modulate Ca V channels. [6] Given that membrane anchoring is necessary for RGKs to exert their suppressive effects on Ca V channels, [6b,7] we reasoned that Ca V channels could be remotely modulated by harnessing light to control the translocation of RGK to the plasma membrane (PM). We therefore engineered aset of optogenetic constructs by using al ight-sensitive heterodimerization system to control the subcellular localization of engineered Rem (Scheme 1a nd Figure S1 in the Supporting Information). We chose the optical dimerizer pair iLID (LOV2-ssrA) and sspB because of their small size,f ast photoresponsive kinetics,l ow background interaction, and minimized perturbation to endogenous signaling pathways. [8] To enable light-inducible cytosol-to-PM translocation of engineered Rem, we set out to install sspB into different positions of Rem 1-266 tagged with the red fluorescent protein mCherry (mCherry-Rem 1-266 )via flexible linkers with varying lengths (Figures S1-3). In parallel, we tethered iLID tagged with the yellow fluorescent protein Venus (Venus-iLID) to the PM with aC -terminal PM-targeting sequence (CAAX) derived from KRas4B [8] or the PM-tethering motif (Lyn11) from the tyrosine-protein kinase Lyn. [9] We then co-transfected these two constructs into HeLa cells and examined the reversible recruitment of cytosolicR em to the PM (Figure 1a ,F igures S1-4). In the dark, mCherry-Rem 1-266 -sspB was evenly distributed in the cytosol (Figure 1a ). Upon blue light illumination, photoexcitation produced ac ovalent adduct between residue C450 of LOV2 and the cofactor FMN,thereby exposing the caged ssrA component of iLID to restore its interaction with sspB.C onsequently,m Cherry-Rem 1-266 -sspB was recruited toward the PM within seconds (t 1/2 , on = 3.2 AE 1.0 sec). Upon withdrawal of light, mCherry-Rem 1-266 -sspB dissociated from the PM-resident ssrA and diffused back to the cytosol (t 1/2 , off = 23.0 AE 2.4 sec;F igure 1, Figure S3 , and Movie S1). After screening over 20 constructs with different combinations of key elements (various Rem fragments,l inkers,P M-targeting motifs,a nd insertion sites), we identified mCherry-Rem1 1-266 -sspB/iLID-CAAX as an ideal candidate because it exhibited an optimal performance with high sensitivity and relatively fast kinetics (Figures S1-S3). To enable anear 1:1co-expression of the two components using as ingle construct within the same cells,w eu sed am ulticistronic expression system by utilizing the selfcleaving 2A peptide (P2A)to generate fluorescent protein (FP)-tagged (mCherry or CFP) Rem1 1-266 -sspB-P2A-iLID-CAAX. [10] We named the system optoRGK and used the FPtagged constructs for further characterization and applications in excitable cells.
To determine whether optoRGK could photo-modulate Ca V channels,weexpressed optoRGK in HEK293 cells stably expressing the human Ca V 1.2 channel components (HEK-Ca V 1.2) [11] and evaluated membrane-depolarization-induced Ca 2+ entry with ar ed genetically encoded Ca 2+ sensor jRGCaMP1b [12] (Figure 2a ,b) or the green Ca 2+ dye Fluo-4 ( Figure S3 ). 50 mm potassium chloride (KCl) was employed to induce membrane depolarization. In the dark, addition of KCl elicited ap ulse of Ca V -mediated Ca 2+ influx in both control and optoRGK-expressing cells (Figure 2, 1 st cycle). Upon blue-light illumination, cells overexpressing optoRGK showed as ignificant reduction in KCl-induced Ca 2+ entry compared to control cells (Figure 2a ,2 nd cycle). Furthermore, Ca 2+ influx could be restored in the absence of blue light (Figure 2a ,3 rd cycle), thereby attesting to the reversibility of optoRGK in the regulation of Ca V channels.I np arallel, we performed electrophysiological studies to independently confirm optoRGK-mediated, light-switchable modulation of Ca V channels in HEK293-Ca V 1.2 cells.I nt he dark, cells expressing optoRGK showed robust whole-cell currents with atypical Ca V I-V relationship and amplitudes similar to those of control cells (maximal peak current density % 21.2 pA/pF, n = 12;F igure 2c,d). However,u pon receiving blue-light stimulation, the amplitudes of depolarization-induced whole-cell currents were significantly diminished (maximal peak current density % 6.3 pA/pF, n = 15;F igure 2c,d). These results clearly established optoRGK as agenetically encoded light-switchable channel modulator that allows optical inhibition of Ca V channels in excitable cells. We next moved on to test optoRGK in C2C12 cells, amouse myoblast cell line [13] with functional Ca V channels. [6b] Again, we observed light-dependent inhibition of Ca 2+ influx in this excitable cell line ( Figure S5 ). To further test optoRGK in more physiologically relevant systems,w ei ntroduced it into HL-1 cardiomyocytes,awell-characterized atrial myocyte culture line derived from the adult mouse that retains many of the differentiated properties of cardiac cells, [14] including rhythmic oscillations of cytosolicC a 2+ (Movie S2). By using Fluo-4 as the Ca 2+ indicator, we first evaluated rhythmic Ca 2+ oscillations in HL-1 cells with and without overexpression of full length Rem or its truncated version Rem (Figure S6 , Movies S3 and S4). Both control cells and HL-1 cells transfected with mCherry-Rem 1-266 -sspB (Figure S6b) exhibited rhythmic Ca 2+ oscillations,w hile cardiomyocytes expressing the full-length Rem failed to evoke Ca 2+ transients ( Figure S6a ). These findings are consistent with the results obtained from C2C12 myoblast cells ( Figure S5 ) and other types of excitable cells. [15] Having validated the use of HL-1 cardiomyocytes to test our tool, we next examined the rhythmic oscillations of cytosolic Ca 2+ (Fluo-4 signals as readout) in HL-1 cells expressing optoRGK. Upon blue-light illumination, mCherry-Rem1 1-266 -sspB translocated from the cytosol to close to the PM within several seconds ( Figure S7 ), accompanied by the attenuation of oscillatory Ca 2+ signals (Figure 3a ,bottom, and Movie S5). By contrast, the control cells displayed regular Ca 2+ oscillations under blue light. To further validate whether such action was reversible in HL-1 cells,we used the red Ca 2+ indicator Cal-590 (excitation at 562 nm without pre-activating optoRGK) rather than Fluo-4 to monitor Ca 2+ oscillations (Figure 3b ). HL-1 cells expressing optoRGK showed regular Ca 2+ spikes in the dark. However, upon blue-light illumination, the rhythmic oscillations were substantially attenuated. Notably,r egular Ca 2+ oscillations were restored in the same HL-1 cardiomyocyte after removal of the light source (Figure 3b ).
Taken together,compared with traditional small-molecule Ca V channel blockers that often lack reversibility,s electivity, and tissue-specificity,e ngineered RGK proteins could serve as promising candidates to enable spatiotemporal control of Ca V channels with as imple pulse of light. This study complements the recent development of engineered stromal interaction molecule 1( STIM1) to photo-regulate endogenous Ca 2+ channels in mammalian cells (e.g., optoSTIM1 [16] and Opto-CRAC [17] ). We anticipate that the optoRGK tool developed in the current study will find broad applications in interrogating aw ide range of Ca 2+ -dependent physiological processes in mammals.
Proof-of-concept experiments have already demonstrated the potential of using RGK to treat heart disease. [18] To test potential in vivo applications,weplan to express optoRGK in the atrioventricular node of rodent models with atrial fibrillation disease, [19] and examine whether photostimulation could suppress aberrant atrioventricular nodal conduction to intervene atrial fibrillation.
Given that RGK proteins primarily exert suppressive effects on high-voltage-activated Ca 2+ (Ca V 1/Ca V 2) channels [20] and that LOV2-based photoswitches have relatively slow kinetics,t he efficacyo fo ptoRGK will likely depend on the distribution and endogenous levels of Ca V channel subtypes in different cell types and tissues.I ni ts current configuration, optoRGK is well suited to modulate cardiomyocytes because of the abundant expression of l-type Ca V 1.1/Ca V 1.2 channels and the relatively long duration of cardiac action potentials.I ts compatibility with neurons and other types of electrically excitable cells (e.g., pancreatic beta cells) remains to be tested. 
